Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes

The Journal of International Medical Research
Tatsuhiko SuzukiToshihiko Inukai

Abstract

Objective This study was performed to evaluate the association of the serum level of angiopoietin-like protein 2 (ANGPTL2) with circulating inflammatory markers and oxidized and modified low-density lipoprotein (LDL) cholesterol as evaluated by lectin-like oxidized LDL receptor 1 ligand containing apolipoprotein B (LAB) in patients with type 2 diabetes. Methods The study included 70 patients with type 2 diabetes hospitalized for glycemic control and 9 control subjects. Results The serum level of ANGPTL2 was significantly higher in the patients with type 2 diabetes than in the healthy controls. There was a significant positive correlation between ANGPTL2 and the high-sensitivity C-reactive protein, fibrinogen, and LAB levels and a significant negative correlation between ANGPTL2 and the estimated glomerular filtration rate (eGFR). Conclusions These results suggest that the serum ANGPTL2 level has a close positive association with inflammatory markers, especially fibrinogen and oxidized and modified LDL as evaluated by LAB. The data also suggest that the serum ANGPTL2 level is influenced by renal function as reflected by the eGFR.

References

Sep 1, 1999·The International Journal of Biochemistry & Cell Biology·S HerrickG Laurent
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Megumi HonjoTatsuya Sawamura
Sep 24, 2004·Physiological Reviews·Roland Stocker, John F Keaney
Mar 22, 2005·Nature Medicine·Yuichi OikeToshio Suda
May 3, 2005·Journal of Lipid Research·Hongfei GeCai Li
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·M W Mosesson
Mar 3, 2007·Journal of Atherosclerosis and Thrombosis·Hiroyuki Itabe, Makiko Ueda
Mar 10, 2007·Nephron. Experimental Nephrology·Hua SunLei-shi Li
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Jan 23, 2010·Clinical Chemistry·Nobutaka InoueTatsuya Sawamura
May 5, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Hirokazu TazumeYuichi Oike
Jul 11, 2012·Current Opinion in Lipidology·Tatsuya SawamuraYoshiko Fujita
Nov 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Fabiana QuagliariniHelen H Hobbs
Apr 23, 2013·Diabetes Research and Clinical Practice·Qin LiRenming Hu
May 15, 2013·Journal of the American Heart Association·Nada FarhatEric Thorin
Nov 16, 2017·Oxidative Medicine and Cellular Longevity·Nathalie Thorin-Trescases, Eric Thorin

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent
ELISA

Software Mentioned

Ekuseru

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.